Office of Diversion Control, US Department of Justice, Drug Enforcement Administration

ABOUT US > What's New

What's New

January 2015

Jose Raul S. Villavicencio, M.D.; Decision and Order (January 23, 2015)

Samuel Mintlow, M.D.; Decision and Order (January 23, 2015)

Removal of Naloxegol From Control (January 23, 2015)

Letter to Registrants: Final Rule Placed Hydrocodone Combinations (HCPs) into Schedule II, effective October 6, 2014 (PDF) (December 2, 2014)


December

Temporary Placement of Three Synthetic Cannabinoids Into Schedule I (December 19, 2014)

Electronic Prescriptions for Controlled Substances: Notice of Approved Certification Process (December 12, 2014)

Johnson Matthey Pharmaceutical Materials, Inc. (December 11, 2014)

Sigma Aldrich Research Biochemicals, Inc. (December 11, 2014)


November

Exemption From Registration for Persons Authorized Under U.S. Nuclear Regulatory Commission or Agreement State Medical Use Licenses or Permits and Administering the Drug Product DaTscan™ (November 25, 2014)

Webinar for Community Agencies: The DEA's Final Rule on Disposal of Controlled Substances

Richard D. Vitalis, D.O.; Decision and Order (November 18, 2014)

Martin L. Korn, M.D.; Decision and Order (November 7, 2014)

Alltech Associates, Inc. (November 7, 2014)

 


October

Removal of Naloxegol From Control (October 29, 2014)

Michael A. White, M.D.; Decision and Order (October 21, 2014)

Letter to Registrants seeks to clarify the DEA position regarding a practitioner’s disposal of pharmaceutical wastage (October 17, 2014)

Fiaz Afzal, M.D.; Decision And Order (October 14, 2014)

Fisher Clinical Services, Inc. (October 8, 2014)

Alkermes Gainesville LLC (October 8, 2014)

Austin Pharma, LLC (October 8, 2014)

Siemens Healthcare Diagnostics, Inc. (October 8, 2014)

Johnson Matthey, Inc. (October 7, 2014)

Noramco, Inc. (October 7, 2014)

Cerilliant Corporation (October 7, 2014)

R & D Systems, Inc. (October 7, 2014)

Chattem Chemicals, Inc. (October 7, 2014)

Meda Pharmaceuticals, Inc. (October 7, 2014)

Alltech Associates, Inc. (October 7, 2014)

The Medicine Shoppe; Decision and Order (October 2, 2014)


September 2014

30-day Notice: U.S. Official Order Forms—Schedules I & II (DEA Form 222) (September 19, 2014)

Chattem Chemicals, Inc.; Correction (September 11, 2014)

Disposal of Controlled Substances; Final Rule (PDF) (September 9, 2014)

Drug Disposal Fact Sheets

Established Aggregate Production Quotas for Schedule I and II Controlled Substances and Assessment of Annual Needs for the List I Chemicals Ephedrine, Pseudoephedrine, and Phenylpropanolamine for 2015 (September 8, 2014)

Fisher Clinical Services, Inc. (September 4, 2014)

Cody Laboratories, Inc. (September 4, 2014)

Mylan Technologies, Inc. (September 4, 2014)

Arizona Department of Corrections, ASPC-Florence (September 4, 2014)

Wildlife Laboratories, Inc. (September 4, 2014)

Akorn, Inc. (September 4, 2014)

Chattem Chemicals, Inc. (September 4, 2014)

Organix, Inc. (September 4, 2014)

National Center for Natural Products Research (NIDA MProject), Inc. (September 4, 2014)


August 2014

Placement of Suvorexant into Schedule IV (August 28, 2014)

Adjustment to the Established 2014 Aggregate Production Quota for Marijuana (August 26, 2014)

Richard C. Quigley, D.O.; Decision and Order (August 26, 2014)

SA INTL GMBH C/O., Sigma Aldrich Co., LLC (August 26, 2014)

Chemtos, LLC (August 26, 2014)

Cerilliant Corporation (August 26, 2014)

PCAS-Nanosyn, LLC (August 26, 2014)

Patheon Pharmaceuticals, Inc. (August 26, 2014)

Final Adjusted Aggregate Production Quotas for Schedule I and II Controlled Substances and Assessment of Annual Needs for the List I Chemicals Ephedrine, Pseudoephedrine, and Phenylpropanolamine for 2014 (August 25, 2014)

Catalent CTS, LLC; Correction (August 25, 2014)

Rescheduling of Hydrocodone Combination Products From Schedule III to Schedule II (August 22, 2014)

30-day Notice: Red Ribbon Week Patch (August 22, 2014)

Glenn R. Unger, D.D.S.; Declaratory Order (August 20, 2014)

Electronic Prescriptions for Controlled Substances Notice of Approved Certification Process (August 20, 2014)

United States Pharmacopeial Convention (August 20, 2014)

Penick Corporation (August 20, 2014)

Catalent CTS, LLC; Correction (August 18, 2014)

Rhodes Technologies (August 18, 2014)

30-Day Notice: Registrants Inventory of Drugs Surrendered (August 5, 2014)

30-Day Notice: Report of Theft or Loss of Controlled Substances (August 5, 2014)

30-Day Notice: Controlled Substances Import/Export Declaration (August 5, 2014)

Almac Clinical Services, Inc. (ACSI) (August 1, 2014)


July 2014

Franklyn Seabrooks, M.D.; Decision and Order (July 30, 2014)

Robert V. Cattani, M.D.; Decision and Order (July 30, 2014)

Fresenius Kabi USA, LLC (July 28, 2014)

60-Day Notice: U.S. Official Order Forms—Schedules I & II (DEA Form 222) (July 17, 2014)

Meridian Medical Technologies (July 14, 2014)

Research Triangle Institute (July 14, 2014)

Moore Clinical Trials, L.L.C.; Decision and Order (July 11, 2014)

Research Triangle Institute (July 11, 2014)

S & B Pharma, Inc. (July 8, 2014)

Placement of Tramadol Into Schedule IV (July 2, 2014)

Proposed Aggregate Production Quotas for Schedule I and II Controlled Substances and Assessment of Annual Needs for the List I Chemicals Ephedrine, Pseudoephedrine, and Phenylpropanolamine for 2015 (July 2, 2014)

Emergency Disaster Relief
Got Drugs? Turn in your unused or expired medication for safe disposal here.
Alert! Extortion Scam

U.S. DEPARTMENT OF JUSTICE  •  DRUG ENFORCEMENT ADMINISTRATION
Office of Diversion Control  •  8701 Morrissette Drive  •  Springfield, VA 22152  •  1-800-882-9539